Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001363810 | SCV001559937 | pathogenic | Tumor predisposition syndrome 3 | 2023-09-15 | criteria provided, single submitter | clinical testing | This variant has not been reported in the literature in individuals affected with POT1-related conditions. This sequence change creates a premature translational stop signal (p.Tyr558Leufs*6) in the POT1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in POT1 are known to be pathogenic (PMID: 32155570). This variant is not present in population databases (gnomAD no frequency). ClinVar contains an entry for this variant (Variation ID: 1055178). For these reasons, this variant has been classified as Pathogenic. |
Ambry Genetics | RCV002404862 | SCV002704450 | pathogenic | Hereditary cancer-predisposing syndrome | 2023-03-16 | criteria provided, single submitter | clinical testing | The c.1672dupT pathogenic mutation, located in coding exon 13 of the POT1 gene, results from a duplication of T at nucleotide position 1672, causing a translational frameshift with a predicted alternate stop codon (p.Y558Lfs*6). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. |